BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30328261)

  • 1. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
    Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
    Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
    Jalal SD
    PLoS One; 2021; 16(2):e0247491. PubMed ID: 33606850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
    Hoffmann J; Rother M; Kaiser U; Thrun MC; Wilhelm C; Gruen A; Niebergall U; Meissauer U; Neubauer A; Brendel C
    Cytometry B Clin Cytom; 2020 Nov; 98(6):476-482. PubMed ID: 32716606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
    Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
    Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
    Li W; Fang P; Fu G; Liang H; Peng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
    Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
    Cytometry B Clin Cytom; 2014 Mar; 86(2):98-105. PubMed ID: 24243815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
    Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
    Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.
    Lesesve JF; Tardy S; Frotscher B; Latger-Cannard V; Feugier P; De Carvalho Bittencourt M
    Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.
    Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA
    Int J Lab Hematol; 2018 Oct; 40(5):533-539. PubMed ID: 29806244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
    Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
    Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?
    Falay M; Serdar MA; Dalgali H; Uçar MA; Dagdaş S; Özet G
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent diagnostic utility of CD20, CD200, CD43 and CD45 in chronic lymphocytic leukaemia.
    Ramalingam TR; Mohanraj S; Muthu A; Prabhakar V; Ramakrishnan B; Vaidhyanathan L; Easow J; Raja T
    Leuk Lymphoma; 2022 Feb; 63(2):377-384. PubMed ID: 34676804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.
    Fan L; Miao Y; Wu YJ; Wang Y; Guo R; Wang L; Shen AL; Chen YY; Xu W; Li JY
    Leuk Lymphoma; 2015; 56(12):3329-35. PubMed ID: 25791119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.
    D'Arena G; Vitale C; Rossi G; Coscia M; Omedè P; D'Auria F; Statuto T; Valvano L; Ciolli S; Gilestro M; Molica S; Bellesi S; Topini G; Panichi V; Autore F; Innocenti I; Musto P; Deaglio S; Laurenti L; Del Vecchio L
    Hematol Oncol; 2018 Mar; ():. PubMed ID: 29602219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the CLLflow score.
    Sorigue M; Franch-Sarto M; Sarrate E; Junca J
    Cytometry B Clin Cytom; 2018 Nov; 94(6):950-952. PubMed ID: 29316199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Lymphoid enhancer-binding factor 1 (LEF-1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features.
    Soliman DS; Al-Kuwari E; Siveen KS; Al-Abdulla R; Chandra P; Yassin M; Nashwan A; Hilmi FA; Taha RY; Nawaz Z; El-Omri H; Mateo JM; Al-Sabbagh A
    Int J Lab Hematol; 2021 Jun; 43(3):515-525. PubMed ID: 33314668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
    Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
    J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
    [No Abstract]   [Full Text] [Related]  

  • 20. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
    Al-Zubaidi HK; Hughes SF
    Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.